258
Views
9
CrossRef citations to date
0
Altmetric
Letter

Chronic eosinophilic leukemia with erythroblastic proliferation and the rare translocation t(8;9)(p22;p24) with PCM1–JAK2 fusion gene: a distinct clinical, pathological and genetic entity with potential treatment target?

, , , , , & show all
Pages 1824-1827 | Received 29 Dec 2011, Accepted 24 Jan 2012, Published online: 13 Mar 2012

References

  • Reiter A, Walz C, Watmore A, . The t(8;9)(p22;p24) is a recurrent abnormality in chronic and acute leukemia that fuses PCM1 to JAK2. Cancer Res 2005;65:2662–2667.
  • Bousquet M, Quelen C, De Mas V, . The t(8;9)(p22;p24) translocation in atypical chronic myeloid leukaemia yields a new PCM1-JAK2 fusion gene. Oncogene 2005;24:7248–7252.
  • Murati A, Gelsi-Boyer V, Adélaïde J, . PCM1-JAK2 fusion in myeloproliferative disorders and acute erythroid leukemia with t(8;9) translocation. Leukemia 2005;19:1692–1696.
  • Heiss S, Erdel M, Gunsilius E, . Myelodysplastic/myeloproliferative disease with erythropoietic hyperplasia (erythroid preleukemia) and the unique translocation (8;9)(p23;p24): first description of a case. Hum Pathol 2005;36:1148–1151.
  • Adélaïde J, Pérot C, Gelsi-Boyer V, . A t(8;9) translocation with PCM1-JAK2 fusion in a patient with T-cell lymphoma. Leukemia 2006;20:536–537.
  • Huang KP, Chase AJ, Cross NC, . Evolutional change of karyotype with t(8;9)(p22;p24) and HLA-DR immunophenotype in relapsed acute myeloid leukemia. Int J Hematol 2008;88:197–201.
  • Dargent JL, Mathieux V, Vidrequin S, . Pathology of the bone marrow and spleen in a case of myelodysplastic/myeloproliferative neoplasm associated with t(8;9)(p22;p24) involving PCM1 and JAK2 genes. Eur J Haematol 2011;86:87–90.
  • Hoeller S, Walz C, Reiter A, . PCM1-JAK2-fusion: a potential treatment target in myelodysplastic-myeloproliferative and other hemato-lymphoid neoplasms. Expert Opin Ther Targets 2011;15:53–62.
  • Thiele J, Kvasnicka HM, Facchetti F, . European consensus on grading bone marrow fibrosis and assessment of cellularity. Haematologica 2005;90:1128–1132.
  • Swerdlow SH, Campo E, Harris NL, . World Health Organization classification of tumors. Pathology and genetics of tumors of hematopoietic and lymphoid tissues. Lyon: IARC Press; 2008.
  • Takatsu K, Nakajima H. IL-5 and eosinophilia. Curr Opin Immunol 2008;20:288–294.
  • Buitenhuis M, Verhagen LP, Cools J, . Molecular mechanisms underlying FIP1L1-PDGFRA-mediated myeloproliferation. Cancer Res 2007;67:3759–3766.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.